| 4DFF: reference: The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia., Ho GD, Michael Seganish W, Bercovici A, Tulshian D, Greenlee WJ, Van Rijn R, Hruza A, Xiao L, Rindgen D, Mullins D, Guzzi M, Zhang X, Bleickardt C, Hodgson R, Bioorg Med Chem Lett. 2012 Feb 9. PMID: 22377514 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).